Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03890861 · ClinicalTrials.gov registry record · NA

Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"

A NA study of Dementia Alzheimer Type, sponsored by Pennington Biomedical Research Center.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT03890861 is a NA study of Dementia Alzheimer Type that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 125 participants, above the 59-participant average among 8 other Dementia Alzheimer Type trials with a reported enrollment target (112% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03890861, a NA study of Dementia Alzheimer Type, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

The RAATE proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. There are three main objectives of the protocol: 1) to determine if a physical activity intervention tailored to older African American adults is effective in modifying cognitive function associated with Alzheimer's Disease, 2) to determine if a physical activity intervention tailored to older African American adults is effective in modifying brain function and structure associated with Alzheimer's Disease, and 3) to determine if a physical activity promotion intervention tailored to African American adults is effective at enhancing physiological parameters. The primary endpoints for the study are episodic memory and executive functioning. The secondary outcomes include anthropometry, blood pressure, brain activation, cerebral blood flow, volume of whole brain and white matter hyperintensities, cardiorespiratory fitness, objectively measured physical activity, circulating hormones, and telomere length.

Conditions Studied

Interventions

  • BEHAVIORAL Physical activity
  • BEHAVIORAL Successful Aging

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2019-08-09
Est. Completion 2026-11
Phase NA

What the Registry Record Tells You About NCT03890861

The ClinicalTrials.gov registry entry for NCT03890861 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 59-participant average among 8 other Dementia Alzheimer Type trials with a reported enrollment target (112% higher). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dementia Alzheimer Type appearing as the primary indexed condition, and to 2 interventions - of which Physical activity is the first listed.

NCT03890861 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT03890861 about?

NCT03890861 is a clinical study titled "Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"". The RAATE proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. There are three main objectives of the protocol: 1) to determine if a ...

What is the current status of trial NCT03890861?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2019-08-09. Estimated completion is 2026-11.

What conditions does trial NCT03890861 study?

This clinical trial studies the following conditions: Dementia Alzheimer Type.

What interventions are being tested in trial NCT03890861?

The interventions under investigation include: Physical activity (BEHAVIORAL), Successful Aging (BEHAVIORAL).

Who is sponsoring clinical trial NCT03890861?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03890861 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia Alzheimer Type

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.